Ampersand Capital Partners Overview

  • Investor Type
  • Growth/​Expansion
  • Status
  • Active
  • Professionals
  • 23
Professionals
  • Investments
  • 167
  • Portfolio
  • 22
  • Exits
  • 78
Exits

Ampersand Capital Partners General Information

Description

Founded in 1988, Ampersand Capital Partners is a private equity firm based in Wellesley, Massachusetts. The firm prefers to be the first institutional investor and focuses on EBITDA-positive lower middle-market healthcare companies that provide products and services within several key healthcare sectors, including laboratory testing services, laboratory products, contract manufacturing, pharma services, specialty pharma, and healthcare services.

Contact Information

Year Founded
1988
Investor Status
Actively Seeking New Investments
Primary Investor Type
Growth/Expansion
Other Investor Types
PE/Buyout
Venture Capital
Primary Office
  • 55 William Street
  • Suite 240
  • Wellesley, MA 02481
  • United States
+1 (781) 000-0000

Ampersand Capital Partners Investments (167)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
00000000 18-Mar-2021 00 000000000 Diagnostic Equipment Generating Revenue 00000 00000000
000 00000000000000 09-Mar-2021 0000 0000 Other Healthcare Services Generating Revenue/Not Profitable
000 00000000 (0000 20-Jan-2021 0000000000 Laboratory Services (Healthcare) Generating Revenue 0000 000
0000000 0000000000 05-Jan-2021 0000000000 Biotechnology Generating Revenue 00000 00000000 00.0
Cadence Fluidics 07-Dec-2020 Buyout/LBO Industrial Supplies and Parts Generating Revenue 00000000 0000000
You’re viewing 5 of 167 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ampersand Capital Partners Exits (78)

Company Name Exit Date Exit Type Exit Size
000000000 11-Feb-2021 000 00000
000000 00000000000 11-Sep-2020 000000000000000000 000.00
0000000 06-Aug-2020 000000000000000000 000.00
00000000 00000000 17-Jan-2020 0000000000
Gyros Protein Technologies 31-Oct-2019 Merger/Acquisition 00000
You’re viewing 5 of 78 exits. Get the full list »

Ampersand Capital Partners Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Ampersand Capital Partners‘s full profile, request access.

Request a free trial

Ampersand Capital Partners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Ampersand Capital Partners Team (46)

Name Title Deals Funds Boards Office
Dana Niles Partner & Chief Operating Officer Wellesley, MA
Richard Charpie Ph.D Founder & Managing Partner 00 0 0 Wellesley, MA
Herbert Hooper Ph.D Managing Partner 00 0 0 Wellesley, MA
David Anderson Ph.D General Partner 00 0 0 Wellesley, MA
David Parker General Partner 00 0 0 Amsterdam, Netherlands
You’re viewing 5 of 46 team members. Get the full list »